Showing 316 results

Filters Content type: News, Editors' picks, About HIV Topic: Drug interactions & pharmacokinetics

Taking two or more different drugs together may result in an alteration in the effectiveness or in the side-effects of one or more of the drugs. Pharmacokinetics (PK) is the study of how a drug is absorbed into the body and distributed in different parts of the body. Pharmacodynamics (PD) is the study of the impact of different concentrations of a drug on the body.

Drug interactions & pharmacokinetics

ViiV Healthcare has obtained marketing approval for the first and only complete long-acting treatment for HIV in Japan

Editor's pick
ViiV press release
31 May 2022
Cancer

Full-Dose Chemotherapy Regimen Appears Safe for Patients With HIV and Cancer

Editor's pick
Oncology Nurse Advisor
16 May 2022
Ageing & HIV

Polypharmacy Common Among Patients Aged 65 or Older With HIV

Editor's pick
Medscape (requires free registration)
28 April 2022
Drug interactions & pharmacokinetics

No Interactions Between Hormone Therapy and PrEP in Transgender Women or Men

Editor's pick
NATAP
24 February 2022
Ageing & HIV

Anticholinergic medications associated with falls and frailty in people ageing with HIV

News
15 February 2022
Injectable & long-acting HIV treatment

Cabenuva Works Well Regardless of Body Weight

Editor's pick
POZ
5 November 2021
HIV treatment for children & young people

WHO Updates Pediatric Dosing Tool for Antiretroviral Medicines

Editor's pick
Medscape (requires free registration)
31 October 2021
Drug interactions & pharmacokinetics

No Drop in Rate of Drug-Drug & Interactions With HIV Drugs Since 1985

Editor's pick
NATAP
27 September 2021
PrEP science

One dose of TAF every three days gets more drug into cells than a daily dose of TDF

News
17 September 2021
Transgender people

Studies confirm that hormone levels in trans women are not greatly affected by PrEP, or vice versa

News
22 July 2021
Drug interactions & pharmacokinetics

Elderly women more likely than men to have inappropriately prescribed medicines

News
25 March 2021
Drug interactions & pharmacokinetics

PrEP does not lower hormone levels in young transgender people, but lower PrEP levels seen in some transgender women

News
16 March 2021
Contraception

Doubling the dose of emergency contraception is a safe and effective way of overcoming efavirenz interaction

News
15 March 2021
PrEP science

Interactions between PrEP and gender-affirming hormone therapy A research briefing

About HIV
March 2021
PrEP science

HPTN 083: Injectable PrEP can make breakthrough infections hard to detect

News
10 March 2021
Injectable & long-acting PrEP

Reformulated islatravir implant should provide PrEP for over a year

News
9 March 2021
PrEP

Sex, PrEP and HIV in trans and non-binary people A research briefing

About HIV
March 2021
Injectable & long-acting PrEP

Once-a-month PrEP pill easily passes its first big test

News
27 January 2021
Drug interactions & pharmacokinetics

Can HIV Meds Interact With COVID-19 Treatment? Here's What We Know

Editor's pick
TheBody
25 November 2020
HIV treatment for children & young people

New neonatal liquid formulations of dolutegravir have comparable bioavailability to dispersible paediatric tablet

Editor's pick
i-Base
16 November 2020
Drug interactions & pharmacokinetics

Study finds diabetes is associated with a 25% reduction in concentration of tenofovir in blood spot samples, but what are the causes and consequences?

News
20 October 2020
Injectable & long-acting HIV treatment

New once-a-week drug could be part of weekly oral treatment

News
13 October 2020
Weight gain & lipodystrophy

Genetics may contribute to weight gain after switching from efavirenz to an integrase inhibitor

News
2 October 2020
HIV treatment for children & young people

Adult doses of dolutegravir can be used by children weighing 20 kg or more

News
15 September 2020